Bolt Biotherapeutics Inc. (BOLT)
NASDAQ: BOLT
· Real-Time Price · USD
5.15
-0.29 (-5.33%)
At close: Aug 15, 2025, 3:59 PM
5.23
1.55%
After-hours: Aug 15, 2025, 04:20 PM EDT
Bolt Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 8.39M | 7.21M | 9.37M | 6.2M | 4.26M | 10.81M | 9.16M | 13.45M | 14.84M | 9.24M | 10.62M | 22.62M | 44.02M | 27.38M | 23.65M | 58.3M | 95.48M |
Short-Term Investments | 30.45M | 40.12M | 44.43M | 67.5M | 87.09M | 91.38M | 110.56M | 112.42M | 111.54M | 159.64M | 160.51M | 153.72M | 146.88M | 158.84M | 189.24M | 186.69M | 171.19M |
Long-Term Investments | 19.11M | 22.88M | 30.6M | 23.83M | 23.23M | 28.18M | 21.64M | 31.22M | 44.59M | 23.94M | 38.43M | 47.28M | 54.31M | 85.35M | 77.64M | 65.94M | 36.24M |
Other Long-Term Assets | 1.03M | 1.04M | 1.27M | 2.07M | 1.76M | 2M | 3.11M | 2.58M | 2.6M | 2.59M | 2.56M | 2.56M | 2.48M | 2.61M | 2.56M | 2.43M | 1.77M |
Receivables | n/a | 1.17M | n/a | n/a | 900K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -2.8M | -2M | -500K | -800K | n/a | n/a | n/a | -200K | n/a | n/a | n/a |
Other Current Assets | 3.67M | 1.29M | 3.35M | 2.93M | 900K | 3.52M | 5.74M | 4.8M | 5.23M | 3.86M | 3.7M | 4.93M | 5.19M | n/a | 9.6M | 3.16M | 4.54M |
Total Current Assets | 42.51M | 50.81M | 57.15M | 76.63M | 95.06M | 105.53M | 125.47M | 130.67M | 131.61M | 172.75M | 174.83M | 181.26M | 196.09M | 189.16M | 222.49M | 248.15M | 271.21M |
Property-Plant & Equipment | 23.21M | 24.89M | 20.32M | 21.64M | 22.85M | 24.08M | 25.14M | 26.23M | 27.39M | 28.52M | 29.68M | 29.13M | 29.91M | 30.6M | 30.87M | 30.55M | 15.42M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 43.35M | 48.82M | 52.19M | 47.55M | 47.84M | 54.25M | 49.89M | 60.03M | 74.57M | 55.06M | 70.68M | 78.97M | 86.7M | 118.56M | 111.06M | 98.92M | 53.43M |
Total Assets | 85.86M | 99.63M | 109.33M | 124.18M | 142.89M | 159.78M | 175.35M | 190.7M | 206.18M | 227.81M | 245.5M | 260.24M | 282.79M | 307.72M | 333.55M | 347.07M | 324.64M |
Account Payables | 1.53M | 1.51M | 1.48M | 2.63M | 2.22M | 2.99M | 3.68M | 3.44M | 1.83M | 3.59M | 3.83M | 3.36M | 4.45M | 3.57M | 5.16M | 1.61M | 2.89M |
Deferred Revenue | 3.08M | 3.02M | 1.97M | 2.02M | 1.91M | 2.2M | 1.94M | 1.69M | 1.6M | 1.99M | 3.17M | 3.51M | 3.45M | 2.87M | 5.21M | 4.33M | 1.5M |
Short-Term Debt | n/a | n/a | -94K | 3M | n/a | 2.78M | 2.68M | 2.58M | 2.48M | n/a | 2.38M | 2.15M | 2.06M | n/a | 2.41M | 2.32M | 1.63M |
Other Current Liabilities | 2.52M | 4.2M | 3.25M | 4.37M | 7.01M | 3.88M | 2.88M | 3.76M | -136K | 4.8M | 1.71M | 882K | 4.92M | 7.5M | 4.57M | 6.25M | 2.71M |
Total Current Liabilities | 13.56M | 15.86M | 18.08M | 17.9M | 16.72M | 20.46M | 18.75M | 17.62M | 16.25M | 23.12M | 24.17M | 18.62M | 19.31M | 21.33M | 23.7M | 19.25M | 12.01M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 132K | n/a | n/a | n/a | n/a | 43K | 43K | 43K | 43K | 42K | 200K | 200K | 204K | 210K | 217K | 233K | 321K |
Total Long-Term Liabilities | 25.49M | 26.58M | 19.22M | 20.42M | 22.01M | 26.59M | 28.34M | 30.95M | 32.24M | 33.18M | 32.88M | 33.65M | 35.09M | 36.27M | 34.94M | 31.93M | 9.38M |
Total Liabilities | 39.05M | 42.43M | 37.3M | 38.32M | 38.73M | 47.04M | 47.1M | 48.56M | 48.49M | 56.3M | 57.06M | 52.27M | 54.4M | 57.6M | 58.64M | 51.18M | 21.39M |
Total Debt | 24.71M | 25.21M | 18.18M | 18.89M | 19.57M | 20.22M | 20.86M | 21.47M | 22.05M | 22.61M | 23.24M | 22.89M | 23.37M | 24.36M | 24.93M | 25.48M | 10.68M |
Common Stock | n/a | n/a | 1K | 1K | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -438.44M | -427.4M | -411.47M | -396.29M | -375.1M | -364.29M | -346.38M | -330.13M | -312.07M | -295.09M | -275.09M | -253.33M | -230.67M | -206.99M | -179.83M | -156.44M | -132.85M |
Comprehensive Income | 40K | 97K | n/a | -44K | -36K | 37K | -174K | -229K | -235K | -919K | -1.71M | -1.8M | -1.4M | -321K | -38K | -23K | -64K |
Shareholders Equity | 46.81M | 57.2M | 72.03M | 85.86M | 104.16M | 112.74M | 128.26M | 142.13M | 157.69M | 171.51M | 188.45M | 207.97M | 228.39M | 250.12M | 274.91M | 295.9M | 303.25M |
Total Investments | 49.56M | 63M | 75.03M | 91.33M | 110.31M | 119.56M | 132.2M | 143.63M | 156.13M | 183.59M | 198.94M | 201M | 201.19M | 244.18M | 266.88M | 252.62M | 207.42M |